The growing peril of drug-resistant superbugs

  05 February 2020

Many in India face a similar fate – they get admitted to hospitals with seemingly treatable illnesses, only to contract HAIs caused by superbugs.

While there are no India-wide estimates of how many people die due to antimicrobial resistance, Laxminarayanan pointed out that a bulk of the deaths take place in hospitals. “So, if I were to prioritise measures to tackle drug resistance, infection control in hospitals would be number one.” To be sure, HAIs have always been a risk to hospitalised patients globally. But increasing antimicrobial resistance is throwing a new spanner in the works; it is turning previously curable maladies into death sentences. The problem is that infection-control is not easy. It requires hospitals to aggressively push a range of best practices, including frequent hand washing, and caution while setting up devices like ventilators and catheters. Not enough hospitals check these boxes.

Author(s): Priyanka Pulla
Effective Surveillance  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!